These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 23589033

  • 1. Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms.
    Sun W, Li Z, Shi Z, Wang B, Gao F, Yang Y, Guo W.
    Eur J Orthop Surg Traumatol; 2014 May; 24(4):525-9. PubMed ID: 23589033
    [Abstract] [Full Text] [Related]

  • 2. Relationship of Plasminogen Activator Inhibitor 1 4G/5G Gene Polymorphism and Nontraumatic Lunatum Avascular Necrosis.
    Gönen M, Yörükoğlu AÇ, Aydemir AN, Gönen GA, Tepeli E, Demirkan AF.
    J Hand Surg Am; 2020 May; 45(5):450.e1-450.e4. PubMed ID: 31806394
    [Abstract] [Full Text] [Related]

  • 3. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults.
    Ringelstein M, Jung A, Berger K, Stoll M, Madlener K, Klötzsch C, Schlachetzki F, Stolz E.
    J Neurol; 2012 Nov; 259(11):2287-92. PubMed ID: 22527222
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
    Sun L, Lv H, Wei W, Zhang D, Guan Y.
    J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
    [Abstract] [Full Text] [Related]

  • 5. Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.
    Liang XN, Xie L, Cheng JW, Tan Z, Yao J, Liu Q, Su W, Qin X, Zhao JM.
    Thromb Res; 2013 Aug; 132(2):158-63. PubMed ID: 23856555
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of the plasminogen activator inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G promoter polymorphism with risk of keloid in a Chinese Han population.
    Wang Y, Long J, Wang X, Sun Y.
    Med Sci Monit; 2014 Oct 28; 20():2069-73. PubMed ID: 25350781
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
    Cagliyan CE, Yuregir OO, Balli M, Tekin K, Akilli RE, Bozdogan ST, Turkmen S, Deniz A, Baykan OA, Aslan H, Cayli M.
    Coron Artery Dis; 2013 May 28; 24(3):196-200. PubMed ID: 23283030
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease.
    Onalan O, Balta G, Oto A, Kabakci G, Tokgozoglu L, Aytemir K, Altay C, Gurgey A, Nazli N.
    J Thromb Thrombolysis; 2008 Dec 28; 26(3):211-7. PubMed ID: 17721742
    [Abstract] [Full Text] [Related]

  • 11. Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.
    Xu F, Liu H, Sun Y.
    Ren Fail; 2016 Dec 28; 38(1):157-62. PubMed ID: 26616527
    [Abstract] [Full Text] [Related]

  • 12. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.
    J Periodontol; 2007 Jul 28; 78(7):1256-63. PubMed ID: 17608581
    [Abstract] [Full Text] [Related]

  • 13. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
    Guan LX, Du XY, Wang JX, Wang RL, Wu ZL, Jiang H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr 28; 21(2):173-5. PubMed ID: 15079805
    [Abstract] [Full Text] [Related]

  • 14. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML, Gómez García E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D.
    Thromb Haemost; 2005 Jan 28; 93(1):92-6. PubMed ID: 15630497
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.
    Thromb Res; 2006 Jan 28; 117(5):487-92. PubMed ID: 15907980
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.
    Incalcaterra E, Meli F, Muratori I, Corrado E, Amato C, Canino B, Ferrara F.
    Thromb Res; 2014 Mar 28; 133(3):371-4. PubMed ID: 24485402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.